ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2508

Significant Improvement of Rheumatoid Arthritis (RA) Outcome with Repeat Application of Disease Management (SSDM) Mobiles Tools: A Cohort Study of RA Patients in China

Jing Yang1, Hongzhi Wang2, Wenqiang Fan3, Hua Wei4, Xinwang Duan5, Rong Mu6, Yu Zhang1, Xiafei Xin7, Jinmei Zou1, Xiaofeng Li8, Jie Wu9, Xiaomei Li10, Guosheng Wang11, Hong Liu1, Fei Xiao12, Hui Xiao12, Yuhua Jia12, Yuan Liu12, Bing Wu12 and Xiaofeng Zeng13, 1Department of rheumatology, Central Hospital of MianYang, Sichuan, Mian Yang, China, 2The First Hospital of Jiaxing, Jiaxing, China, 3Department of rheumatology, Central Hospital of XinXiang, Henan, XinXiang, China, 4No 98,Nantong West Rd,Yangzhou, Northern Jiangsu People's Hospital, Yangzhou, China, 5Department of rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, China, 6Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China, 7Ningbo First Hospital, Zhejiang, Ningbo, China, 8The Second Affiliated Hospital of Shanxi Medical College, Taiyuan, China, 9Central Hospital of XinXiang, Henan, XinXiang, China, 10Department of Rheumatology and Immunology, Anhui Medical University Affiliated Provincial Hospital, China, Hefei, Anhui, China, 11Department of rheumatology, Anhui Medical University Affiliated Provincial Hospital, Hefei, China, 12Gothic Internet Technology Corporation, Shanghai, China, 13Department of Rheumatology and Immunology, Peking Union Medical College Hospital, Beijing, China

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Disease Activity, Health Assessment Questionnaire, rheumatoid arthritis (RA) and self-management

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster III: Treatment – Monitoring, Outcomes, Adverse Events

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:  There are more than 5 million rheumatoid arthritis (RA) patients in China, but only 5,000 rheumatologists. Treat-to-Target (T2T) strategy are critical for the treatment of RA, but the Chinese rheumatologists can hardly provide patients with a complete assessment in the clinic due to limited time. The purpose of this study is to explore the effectiveness of applying SSDM in improvement of disease activity after repeated self-assessment in Chinese RA patients.

Methods:  The SSDM includes interfaces of both physicians’ and patients’ application. After entering the data of lab test records, treatment regiments, and executing DAS28 assessment by patients, all data can be synchronized automatically to the authorized physicians’ mobile tool. The rheumatologist can adjust treatment regiments base on patients’ profile. From August 2014 to June 2016, 126 rheumatologists from 83 hospitals in China participated in the study. Patients were educated to assess DAS28 with SSDM and asked to repeat the self-assessment once a month. Descriptive statistics were performed for patient and disease characteristics. According to DAS28 scores, disease activity was divided into four groups: remission (Rem), low disease activity (LDA), moderate disease activity (MDA) and high disease activity (HDA).

Results:  1,058 RA patients with repeated self-assessment of DAS 28 were recruited, 819 (77.4%) women and 239 (22.6%) men respectively. Mean age was 48.3 ± 13.1 (11 to 83) years. Mean interval of repeat self-assessment was 38.2±38.1 days. Mean self-assessment frequency were 3.39±2.84 (2 to 31) times. Mean DAS28 score was 3.78 ± 1.45 (0.56 to 8.66) at baseline and 3.31 ± 1.35 (0.08 to 9.07) at the last assessment. Proportion of patients in Rem, LDA, MDA and HDA was 22.12%, 16.26%, 43.29% and 18.34% respectively at baseline, and changed into 32.61%, 18.81%, 39.22% and 9.36% at the last assessment. The rate of T2T (DAS28≤3.2) at the last assessment was higher than that of baseline significantly (P<0.01). The rate of HDA patients for last assessment was significantly lower than baseline (P<0.01). To further explore weather tight control of disease activity with SSDM could influence RA patients’ outcome, we stratified the patients who did not achieve clinical remission (DAS>2.6) at baseline into twice assessments group and multiple assessments group with 6 months follow-up. The result showed that 149 patients made only twice assessments of DAS28 within 160.8±94.9 (60-578) days. Their mean DAS28 score was 4.27±1.15 (2.61 to 7.86) at baseline and improvement of DAS28 score was 0.55±1.51 (-4.49 to 4.18) at their last assessment. While another 170 patients made 4 to 10 times of self-assessment during 178.9±139.3 (28 to 648) days follow-up. Their mean DAS28 score was 4.24±1.10 (2.61 to 7.77) at baseline and average improvement of DAS28 score was 1.09±1.37 (-1.86 to 5) at the last assessment, which was significantly better than patients who had only two self-assessments (T=3.331, P=0.001).

Conclusion:  Under repeat self-assessment of DAS28 using SSDM, RA patients can achieve better T2T result. SSDM can assist rheumatologist to rationally adjust treatment for RA patients.


Disclosure: J. Yang, None; H. Wang, None; W. Fan, None; H. Wei, None; X. Duan, None; R. Mu, None; Y. Zhang, None; X. Xin, None; J. Zou, None; X. Li, None; J. Wu, None; X. Li, None; G. Wang, None; H. Liu, None; F. Xiao, None; H. Xiao, None; Y. Jia, None; Y. Liu, None; B. Wu, None; X. Zeng, None.

To cite this abstract in AMA style:

Yang J, Wang H, Fan W, Wei H, Duan X, Mu R, Zhang Y, Xin X, Zou J, Li X, Wu J, Li X, Wang G, Liu H, Xiao F, Xiao H, Jia Y, Liu Y, Wu B, Zeng X. Significant Improvement of Rheumatoid Arthritis (RA) Outcome with Repeat Application of Disease Management (SSDM) Mobiles Tools: A Cohort Study of RA Patients in China [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/significant-improvement-of-rheumatoid-arthritis-ra-outcome-with-repeat-application-of-disease-management-ssdm-mobiles-tools-a-cohort-study-of-ra-patients-in-china/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/significant-improvement-of-rheumatoid-arthritis-ra-outcome-with-repeat-application-of-disease-management-ssdm-mobiles-tools-a-cohort-study-of-ra-patients-in-china/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology